Yahoo: J&J’s Impella heart pump shows no patient benefit in 2 trials The results challenge the rapid growth of Impella support during high-risk PCI. Investigators say a reckoning is needed. Fierce Biotech: Johnson & Johnson’s Impella pumps miss the mark in 2 major coronary studies Two separate randomized trials of Johnson & Johnson’s miniaturized Impella heart pumps failed to illustrate the devices’ benefits, spanning specific cases in patients with blockages in their coronary ...

Context Explanation

Johnson & Johnson’s Impella pumps miss the mark in 2 major coronary studies MedPage Today on MSN: Impella flops for acute coronary syndrome patients not in shock MassDevice: Johnson & Johnson MedTech shares findings for Impella CP in left ventricle support This screenshot from an Abiomed video demonstrates placement of the Impella 2.5 and Impella CP. Delivered in a minimally invasive way, Impella pumps actively unload the heart, aiding native heart ...